| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Revenue | $366K | — |
| Cost of Revenue | $274K | — |
| Gross Profit | $92K | — |
| R&D Expense | $77.4M | +257.4% |
| SG&A Expense | $215.8M | +186.5% |
| Operating Income | -$377.8M | -289.5% |
| Pre-tax Income | -$1.02B | -37.5% |
| Income Tax | -$11.0M | -3839.2% |
| Net Income | -$972.3M |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $155.3M | +187.1% |
| Accounts Receivable | $672K | — |
| Inventory | $16.8M | — |
| Current Assets | $198.1M | +129.5% |
| Total Assets | $421.7M | +39.4% |
| Current Liabilities | $139.6M | +14.2% |
| Long-term Debt | $7.5M | -17.3% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$179.2M | -172.3% |
| Capital Expenditures | $14.5M | +25.0% |
| Investing Cash Flow | -$107.9M | -128.9% |
| Financing Cash Flow | $358.4M | +81.7% |
| Free Cash Flow | -$193.7M | -150.2% |
| -31.5% |
| EPS (Basic) | -$1574.14 | — |
| EPS (Diluted) | -$1574.14 | — |
| Total Liabilities |
| $148.9M |
| +2.2% |
| Stockholders' Equity | $209.0M | +256.0% |